论文部分内容阅读
目的:对卡孕栓联合催产素防治剖宫产产后出血的应用价值进行探讨。方法:选取2011年1月-2014年12月来永平县妇幼保健院就诊的100例剖宫产术患者作为研究对象,随机分为观察组和对照组,各50例。给予不同治疗方案进行预防,比较两组患者的产后出血情况。结果:观察组患者的不良反应发生率是4.0%,对照组患者是0%,差异无统计学意义(P>0.05)。观察组患者的产后出血量为(215.5±69.3)m L,对照组为(314.7±74.5)m L,差异具有统计学意义(P<0.05);观察组患者的产后出血发生率2.0%低于对照组12.0%,差异具有统计学意义(P<0.05)。结论:卡孕栓联合催产素在防治剖宫产产后出血中的临床效果显著,降低剖宫产术患者的产后出血发生率与死亡率,且不良反应发生率与单独用药相差不大,具备很高的安全性与可靠性。
Objective: To investigate the application value of carbamazepine combined with oxytocin in prevention and treatment of cesarean section postpartum hemorrhage. Methods: A total of 100 cases of cesarean section from January 2011 to December 2014 in the MCH hospital of Yongping County were selected as study subjects and randomly divided into observation group and control group, 50 cases each. Give different treatment programs to prevent, compare the postpartum hemorrhage of two groups of patients. Results: The incidence of adverse reactions in the observation group was 4.0% and in the control group was 0%, the difference was not statistically significant (P> 0.05). Postpartum hemorrhage was (215.5 ± 69.3) m L in the observation group and (314.7 ± 74.5) m L in the control group, with a statistically significant difference (P <0.05). The incidence of postpartum hemorrhage in the observation group was 2.0% The control group 12.0%, the difference was statistically significant (P <0.05). Conclusions: The clinical effect of carbamazepine combined with oxytocin in preventing and treating hemorrhage after cesarean section was significant, which reduced the incidence of postpartum hemorrhage and mortality in cesarean section patients, and the incidence of adverse reactions was similar to that of drug alone High safety and reliability.